Indications and uses
Helps relieve the pain, ithcing and burning associated with hemorrhoids and other anorectal disorders.
Helps relieve the pain, ithcing and burning associated with hemorrhoids and other anorectal disorders.
Directions: When practical, clean the affected area with mild soaping warm water and rinse thoroughly. Gently dry by patting or blotting with a toilet tissue or soft cloth before applying. Adult and children 12 years of age and older, apply to affected area not more than 6 times a day. Children under 12 years of age: do not use, ask a doctor
Lidocaine 5% w/w
Local Anesthetic
Helps relieve the pain, ithcing and burning associated with hemorrhoids and other anorectal disorders.
For External Use Only
Rectal bleeding occurs
Condition worsens
Symptoms persist for more than 7 days or clear up and return within a few days
Symptoms being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase.
Avoid contact with the eyes
do not use more than directed unless told to do so by a doctor
do not put directly into the rectum by using fingers or any mechanical device or applicator
Ask doctor before use
If swallowed get medical help or contact a Poison Control Center right away
Directions:
When practical, clean the affected area with mild soaping warm water and rinse thoroughly.
Gently dry by patting or blotting with a toilet tissue or soft cloth before applying.
Adult and children 12 years of age and older, apply to affected area not more than 6 times a day.
Children under 12 years of age: do not use, ask a doctor
Store at 20º-25ºC (68º-77ºF)
Benzyl alcohol, Carbomer 940, Cholesterol, Hydrogenated Lecithin, Isopropyl myristate, Propylene glycol,Trolamine, Vitamin E, polysorbate 80, propylene glycol, purified water
Call 1-888-296-9067
Trifecta Pharmaceuticals USA™
101 NE Third Avenue, Suite 1500
Ft. Lauderdale, FL. 33301, USA
1-888-296-9067
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0860003665770 | GTIN-13: 0860003665770 EAN-13: 0860003665770 GTIN-12: 860003665770 UPC-A: 860003665770 GTIN storage (14 digits): 00860003665770 | 4074 RECTAEASE HEMORRHID RELIEF CREAM WITH 5 percent LIDOCAINE 1OZ NO FINGER CO....jpg |
| Data code | Code 128 | X0032F9KM5 | Recta ease Hemorrhoidal Relief Cream 1oz 2pk_box CDER 120125.jpg | |
| Data code | Code 128 | X003F7469R | Recta ease Hemorrhoidal Relief Cream 1oz 3pk_box CDER 120125.jpg |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 69396-070 | 69396-070-01, 69396-070-22, 69396-070-33 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LIDOCAINE | 98PI200987 | ACTIB |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| ALPHA-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| CHOLESTEROL | 97C5T2UQ7J | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| LIGHT MINERAL OIL | N6K5787QVP | IACT |
| ALOE BARBADENSIS LEAF JUICE | RUE8E6T4NB | IACT |
| CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE | 0A5MM307FC | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 6 | 2026-03-04 | full-release | 2026-06-01 01:48:55 |
| 5 | 2025-12-08 | monthly-update | 2026-06-03 17:53:11 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RectaEase Hemorrhoid Relief Cream | LIDOCAINE | Trifecta Pharmaceuticals USA LLC | c054921a-9f1b-7c75-e053-2995a90a1738 | 2026-07-20 | Warnings | 69396-070-01 69396-070-22 69396-070-33 69396-070 69396007022 69396007033 69396007001 57165430-c79f-2013-e063-6294a90a03be c054921a-9f1b-7c75-e053-2995a90a1738 |
Adverse event summaries are temporarily unavailable. Other product information remains available.